ArticlePDF Available

Comprehensive Management of Type 2 Diabetes Mellitus by Acupuncture, Ozone Therapy and Following Suo-Xihealthy Life Style Modification

Authors:

INTRODUCTION
D
       

         


   

    
       

      

    
 

       
    
       
     
       
        

        
     
     

CASE REPORT
Comprehensive Management of Type 2 Diabetes
Mellitus by Acupuncture, Ozone Therapy and
Following Suo-Xihealthy Life Style Modication
Dr. SM. Shahidul Islam1, Sabina Yasmin2, Shayita Islam3, Mohammad Shajib Sheik4, Dr. Rehana
Akter Lima5
1Visiting Consultant & Acupuncture Specialist, Suo-Xi Hospital (Acupuncture), Shaan Tower, Chamelibag,
Santinagar, Dhaka, Bangladesh, 2CEO, Suo-Xi Hospital (Acupuncture), Shaan Tower, Chamelibag, Santinagar,
Dhaka, Bangladesh, 3Associate writer, Suo-Xi Hospital (Acupuncture), Shaan Tower, Chamelibag, Santinagar,
Dhaka, Bangladesh, 4Managing Director, Suo-Xi Hospital (Acupuncture), Shaan Tower, Chamelibag, Santinagar,
Dhaka, Bangladesh, 5Medical Ocer, Suo-Xi Hospital (Acupuncture), Shaan Tower, Chamelibag, Santinagar,
Dhaka, Bangladesh
ABSTRACT
 
         





Key words:              

Address for correspondence:


DOI
© 2024 The Author(s). This open access article is distributed under a Creative Commons Attribution (CC-BY) 4.0 license

 et al 

      
  
     
  
      

 
     
      
  

      



 
       




    

  

     
        
       
       
   

     
    
  
  
       
    
      

CASE PRESENTATION

    
            
         
           
        
   



TREATMENT APPROACH
Lifestyle Modication
       

       
          

    
 
         

Ozone Therapy
    


       
 
     

Acupuncture
       
       
     

       
       

INVESTIGATIONS AND MONITORING

         
    

Initial Assessment (29.11.23)

     

       
   
     

Follow-Up Assessment (02.01.24)
      

      



 et al 

       



 
      
        
     
     
       
        
      



Figure I. Before Treatment

 et al 

Figure II: After Treatment
Figure 2. After Treatment
DISCUSSION
        
  

       
      

       
       

      
  

    

        
       


    
     
        
        
    
    

       
   





 et al 



        

        

    
       
      
   
        

      
         

       
   
          

LIMITATIONS AND FUTURE
RESEARCH
         
     
        
      


Future Research Efforts Should Focus On
    
    
       

      
       


    

      

CONCLUSION

       


      
      


       
       
       

REFERENCES
         



        
    

         
       


 
   

      
       

    
      
      
   





    

       


        





     



     

 et al 




 
       




  
 

         

         
        

  


       


           
           

       

How to cite this article: 
       
      
     


ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
There is no standard meal plan or eating pattern that works universally for all people with diabetes (1). In order to be effective, nutrition therapy should be individualized for each patient/client based on his or her individual health goals; personal and cultural preferences (241,242); health literacy and numeracy (243,244); access to healthful choices (245,246); and readiness, willingness, and ability to change. Nutrition interventions should emphasize a variety of minimally processed nutrientdense foods in appropriate portion sizes as part of a healthful eating pattern and provide the individual with diabetes with practical tools for day-to-day food plan and behavior change that can be maintained over the long term.
Article
Full-text available
nsulin resistance in muscle and liver and -cell failure represent the core pathophysiologic defects in type 2 diabetes. It now is recognized that the -cell failure occurs much earlier and is more severe than previously thought. Subjects in the upper tertile of impaired glucose tolerance (IGT) are maximally/near- maximally insulin resistant and have lost over 80% of their -cell function. In addition to the muscle, liver, and -cell (triumvirate), the fat cell (accelerated lipolysis), gastroin- testinal tract (incretin deficiency/resistance), -cell (hyperglucagonemia), kidney (increased glucose reab- sorption), and brain (insulin resistance) all play important roles in the development of glucose intolerance in type 2 diabetic individuals. Collectively, these eight players com- prise the ominous octet and dictate that: 1) multiple drugs used in combination will be required to correct the multi- ple pathophysiological defects, 2) treatment should be based upon reversal of known pathogenic abnormalities and not simply on reducing the A1C, and 3) therapy must be started early to prevent/slow the progressive -cell failure that already is well established in IGT subjects. A treatment paradigm shift is recommended in which com- bination therapy is initiated with diet/exercise, metformin (which improves insulin sensitivity and has antiathero- genic effects), a thiazolidinedione (TZD) (which improves insulin sensitivity, preserves -cell function, and exerts antiatherogenic effects), and exenatide (which preserves -cell function and promotes weight loss). Sulfonylureas are not recommended because, after an initial improve- ment in glycemic control, they are associated with a progressive rise in A1C and progressive loss of -cell function.
Article
Full-text available
After five decades characterized by empiricism and several pitfalls, some of the basic mechanisms of action of ozone in pulmonary toxicology and in medicine have been clarified. The present knowledge allows to understand the prolonged inhalation of ozone can be very deleterious first for the lungs and successively for the whole organism. On the other hand, a small ozone dose well calibrated against the potent antioxidant capacity of blood can trigger several useful biochemical mechanisms and reactivate the antioxidant system. In detail, firstly ex vivo and second during the infusion of ozonated blood into the donor, the ozone therapy approach involves blood cells and the endothelium, which by transferring the ozone messengers to billions of cells will generate a therapeutic effect. Thus, in spite of a common prejudice, single ozone doses can be therapeutically used in selected human diseases without any toxicity or side effects. Moreover, the versatility and amplitude of beneficial effect of ozone applications have become evident in orthopedics, cutaneous, and mucosal infections as well as in dentistry.
Article
Full-text available
The recent success of pancreatic islet transplantation has generated considerable enthusiasm. To better understand the quality and characteristics of human islets used for transplantation, we performed detailed analysis of islet architecture and composition using confocal laser scanning microscopy. Human islets from six separate isolations provided by three different islet isolation centers were compared with isolated mouse and non-human primate islets. As expected from histological sections of murine pancreas, in isolated murine islets alpha and delta cells resided at the periphery of the beta-cell core. However, human islets were markedly different in that alpha, beta, and delta cells were dispersed throughout the islet. This pattern of cell distribution was present in all human islet preparations and islets of various sizes and was also seen in histological sections of human pancreas. The architecture of isolated non-human primate islets was very similar to that of human islets. Using an image analysis program, we calculated the volume of alpha, beta, and delta cells. In contrast to murine islets, we found that populations of islet cell types varied considerably in human islets. The results indicate that human islets not only are quite heterogeneous in terms of cell composition but also have a substantially different architecture from widely studied murine islets.
Article
Full-text available
Oxidative stress is suggested to have an important role in the development of complications in diabetes. Because ozone therapy can activate the antioxidant system, influencing the level of glycemia and some markers of endothelial cell damage, the aim of this study was to investigate the therapeutic efficacy of ozone in the treatment of patients with type 2 diabetes and diabetic feet and to compare ozone with antibiotic therapy. A randomized controlled clinical trial was performed with 101 patients divided into two groups: one (n = 52) treated with ozone (local and rectal insufflation of the gas) and the other (n = 49) treated with topical and systemic antibiotics. The efficacy of the treatments was evaluated by comparing the glycemic index, the area and perimeter of the lesions and biochemical markers of oxidative stress and endothelial damage in both groups after 20 days of treatment. Ozone treatment improved glycemic control, prevented oxidative stress, normalized levels of organic peroxides, and activated superoxide dismutase. The pharmacodynamic effect of ozone in the treatment of patients with neuroinfectious diabetic foot can be ascribed to the possibility of it being a superoxide scavenger. Superoxide is considered a link between the four metabolic routes associated with diabetes pathology and its complications. Furthermore, the healing of the lesions improved, resulting in fewer amputations than in control group. There were no side effects. These results show that medical ozone treatment could be an alternative therapy in the treatment of diabetes and its complications.
Article
Oxidative stress and inflammation play key roles in the pathogenesis of Multiple sclerosis (MS). Different drugs have been used in the clinical practice, however, there is not a completely effective treatment. Due to its potential therapeutic action, medical ozone represents a promising approach for neurodegenerative disorders. The aim of the present study was to address the role of ozone therapy on the cellular redox state in MS patients. Ozone (20 μg/ml) was administered three times per week during a month by rectal insufflation. The effect of ozone therapy on biomarkers of oxidative stress and inflammation was addressed by spectrophotometric and immunoenzymatic assays. Furthermore, we investigated the action of ozone on CK2 expression and Nrf2 phosphorylation by western blotting analysis. Medical ozone significantly improved (P < 0.05) the activity of antioxidant enzymes and increased the levels of cellular reduced glutathione. In accordance, a significant reduction (P < 0.05) of oxidative damage on lipids and proteins was observed in ozone-treated patients. As well, the levels of pro-inflammatory cytokines TNFα and IL-1β were lower after ozone treatment. Ozone therapy incremented the CK2 expression together with Nrf2 phosphorylation in mononuclear cells of MS patients. These findings suggest that ozone´s antioxidant and anti-inflammatory effects might be partially associated with an induction of Nrf2 phosphorylation and activation. These results provide new insights on the molecular events modulated by ozone, and pointed out ozone therapy as a potential therapeutic alternative for MS patients.
Article
IN BRIEF This review offers a discussion of various strategies for the prevention of type 2 diabetes. It includes results from recent clinical trials targeting patients who are at highest risk for the development of diabetes, with a particular emphasis on lifestyle modification strategies and the implementation of such programs in community-based settings.
Book
The most widely read textbook in the history of medicine -- made even more essential to practice and education by an unmatched array of multi-media content DVD contains 53 chapters not found in the book, hundreds of bonus illustrations, and important procedural videos Through six decades, no resource has matched the encylopedic scope, esteemed scholarship, and scientific rigor of Harrison's Principles of Internal Medicine. Both an educational tool and a clinical reference, it remains the most universally respected textbook in all of medical publishing and the pinnacle of current medical knowledge. The eighteenth edition of Harrison's features expanded and more in-depth coverage of key issues in clinical medicine, pathophysiology, and medical education. The acclaimed Harrison's DVD has been updated to include 53 chapters not found in the book, all-new procedural videos commissioned especially for Harrison's, a masterpiece video from internationally renowned neurologist Martin Samuels on the neurological exam, and hundreds of bonus videos. Now presented in two volumes New text design greatly enhances readability New chapters on cutting-edge issues in clinical medicine Expanded fovus on global considerations of health and disease More evidence-based than ever How-to videos cover topics such as central venous line placement, endotracheal intubation, pericardiocentesis, and thoracentis NEW print chapters include: World Demographics of Aging The Biology of Aging Clinical Problems of Aging The Human Microbiome Acinetobacter Infections Antiphospholipid Antibody Syndrom NEW DVD-only chapters include: Primary Care in Low and Middle Income Countries Neoplasia During Pregnancy Fluid and Electrolyte Imbalances and Acid-Base Disturbances: Case Examples Less Common Malignancies of Lymphoid Cells Interstitial Cystitis/Painful Bladder Syndrome The Schilling Test War-Related Neuro-Psychiatric Illness High-Altitude Illness The Clinical Laboratory in Modern Healthcare Authoritative Content Essential to Medical Practice and Education: Condensed Table of Contents: Part 1: General Considerations in Clinical Medicine; Part 2: Cardinal Manifestations and Presentation of Disease; Section 1: Pain; Section 2: Alterations in Body Temperature; Section 3: Nervous System Dysfunction; Section 4: Disorders of the Eyes, Ears, Nose, and Throat; Section 5: Alterations in Circulatory and Respiratory Functions; Section 6: Alterations in Gastrointestinal Function; Section 7: Alterations in Renal and Urinary Tract Function; Section 8: Alterations in Sexaul Function and Reproduction; Section 9: Alterations in the Skin; Section 10: Hematologic Alterations; Part 3: Genes, the Environment, and Disease; Part 4: Regenerative Medicine; Part 5: Aging; Part 6: Nutrition; Part 7: Oncology and Hematology; Section 1: Neoplastic Disorders; Section 2: Hematopoietic Disorders; Section 3: Disorders of Hemostasis; Part 8: Infectious Diseases; Section 1: Basic Considerations in Infectious Diseases; Section 2: Clinical Syndromes: Community-Acquired Infections; Section 3: Clinical Syndromes: Health Care Associated Infections; Section 4: Approach to Therapy for Bacterial Diseases; Section 5: Diseases Caused by Gram-Positive Bacteria; Section 6: Diseases Caused by Gram-Negative Bacteria; Section 7: Miscellaneous Bacterial Infections; Section 8: Mycobacterial Diseases; Section 9: Spirochetal Diseases; Section 10: Diseases Caused by Rickettsia, Mycoplasmas, and Chlamydiae; Section 11: Viral Diseases: General Considerations; Section 12: Infections Due to DNA Viruses; Section 13: Infections Due to DNA and RNA Respiratory Viruses; Section 14: Infections Due to Human Immunodeficiency Virus and Other Retroviruses; Section 15: Infections Due to RNA Viruses; Section 16: Fungal and Algal Infections; Section 17: Protozoal and Helminthic Infections: General Considerations; Section 18: Protozoal Infections; Part 9: Terrorism and Clinical Medicine; Part 10: Disorders of the Cardiovascular System; Section 1: Introduction to Cardiovascular Disorders; Section 2: Diagnosis of Cardiovascular Disorders; Section 3: Disorders of Rhythm; Section 4: Disorders of the Heart; Section 5: Vascular Disease; Part 11: Disorders of the Respiratory System; Section 1: Diagnosis of Respiratory Disorders; Section 2: Diseases of the Respiratory System; Section 3: Neurologic Critical Care; Section 4: Oncologic Emergencies; Part 13: Disorders of the Kidney and Urinary Tract; Part 14: Disorders of the Gastrointestinal System; Section 1: Disorders of the Alimentary Tract; Section 2: Liver and Billiary Tract Disease; Section 3: Disorders of the Pancreas; Part 15: Disorders of the Immune System, Connective Tissue and Joints; Section 1: The Immune System in Health and Diseases; Section 2: Disorders of Immune-Mediated Injury; Section 3: Disorders of the Joints and Adjacent Tissues; Part 16: Endocrinology; Section 2: Disorders of Bone and Mineral Metabolism; Section 3: Disorders of Intermediary Metabolism; Part 17: Neurologic Disorders; Section 1: Diagnosis of Neurologic Disorders; Section 2: Diseases of the Central Nervous System; Section 3: Nerve and Muscle Disorders; Section 4: Chronic Fatigue Syndrome; Section 5: Psychiatric Disorders; Section 6: Allcoholism and Drug Dependency; Part 18: Poisoning, Drug Overdose, and Evenomation; Part 19: High Altitude and Decompression Sickness
Article
Strength training represents an alternative to endurance training for patients with type 2 diabetes. Little is known about the effect on insulin action and key proteins in skeletal muscle, and the necessary volume of strength training is unknown. A total of 10 type 2 diabetic subjects and 7 healthy men (control subjects) strength-trained one leg three times per week for 6 weeks while the other leg remained untrained. Each session lasted no more than 30 min. After strength training, muscle biopsies were obtained, and an isoglycemic-hyperinsulinemic clamp combined with arterio-femoral venous catheterization of both legs was carried out. In general, qualitatively similar responses were obtained in both groups. During the clamp, leg blood flow was higher (P < 0.05) in trained versus untrained legs, but despite this, arterio-venous extraction glucose did not decrease in trained legs. Thus, leg glucose clearance was increased in trained legs (P < 0.05) and more than explained by increases in muscle mass. Strength training increased protein content of GLUT4, insulin receptor, protein kinase B-alpha/beta, glycogen synthase (GS), and GS total activity. In conclusion, we found that strength training for 30 min three times per week increases insulin action in skeletal muscle in both groups. The adaptation is attributable to local contraction-mediated mechanisms involving key proteins in the insulin signaling cascade.
Article
Individuals with insulin resistance are characterized by impaired insulin action on whole-body glucose uptake, in part due to impaired insulin-stimulated glucose uptake into skeletal muscle. A single bout of exercise increases skeletal muscle glucose uptake via an insulin-independent mechanism that bypasses the typical insulin signalling defects associated with these conditions. However, this 'insulin sensitizing' effect is short-lived and disappears after approximately 48 h. In contrast, repeated physical activity (i.e. exercise training) results in a persistent increase in insulin action in skeletal muscle from obese and insulin-resistant individuals. The molecular mechanism(s) for the enhanced glucose uptake with exercise training have been attributed to the increased expression and/or activity of key signalling proteins involved in the regulation of glucose uptake and metabolism in skeletal muscle. Evidence now suggests that the improvements in insulin sensitivity associated with exercise training are also related to changes in the expression and/or activity of proteins involved in insulin signal transduction in skeletal muscle such as the AMP-activated protein kinase (AMPK) and the protein kinase B (Akt) substrate AS160. In addition, increased lipid oxidation and/or turnover is likely to be another mechanism by which exercise improves insulin sensitivity: exercise training results in an increase in the oxidative capacity of skeletal muscle by up-regulating lipid oxidation and the expression of proteins involved in mitochondrial biogenesis. Determination of the underlying biological mechanisms that result from exercise training is essential in order to define the precise variations in physical activity that result in the most desired effects on targeted risk factors, and to aid in the development of such interventions.